BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 6806805)

  • 1. [Formation of a filterable form of the causative agent of tuberculosis in the chemotherapy process (an experimental study)].
    Khomenko AK; Golyshevskaia VI; Korolev MB; Drozdov SG
    Probl Tuberk; 1982 Mar; (3):50-4. PubMed ID: 6806805
    [No Abstract]   [Full Text] [Related]  

  • 2. Variability of mycobacterial population in the process of the experimental chemotherapy of tuberculosis.
    Golyshevskaya VI
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1986; 35(3):263-6. PubMed ID: 3027864
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical course and chemotherapy of hyperchronic destructive pulmonary tuberculosis].
    Mamolat AS; Bialik IB; Khutorskaia VD
    Probl Tuberk; 1985; (10):24-8. PubMed ID: 3934660
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effectiveness of different chemotherapy regimens with pulmonary tuberculosis patients based on the data from a comprehensive bacteriological study].
    Muratov VV; Pashkov IuN; Chukanov VI
    Probl Tuberk; 1983 May; (5):34-8. PubMed ID: 6408636
    [No Abstract]   [Full Text] [Related]  

  • 5. [Improved methods of isolating altered forms of Mycobacterium tuberculosis in patients with stable destructive changes in lung tissue].
    Golyshevskaia VI; Akhunov ShB; Bibergal' EA
    Probl Tuberk; 1987; (10):61-5. PubMed ID: 3122201
    [No Abstract]   [Full Text] [Related]  

  • 6. [Bacterial excretion and the bacteriostatic activity of the blood in the chemotherapy of middle-aged and elderly tuberculosis patients].
    Ginzburg TS; Iakimets VP
    Probl Tuberk; 1983 May; (5):57-61. PubMed ID: 6408638
    [No Abstract]   [Full Text] [Related]  

  • 7. [Outlook for using a short course of chemotherapy in tuberculosis].
    Anastasatu C; Corlan E
    Probl Tuberk; 1987; (10):31-4. PubMed ID: 3122200
    [No Abstract]   [Full Text] [Related]  

  • 8. [Trends in the development of drug resistance in the causative agent of tuberculosis (based on data from an examination of hospital patients)].
    Priĭmak AA; Dolzhanskiĭ VM; Sagalovich VIa; El'murzaeva AA
    Probl Tuberk; 1985; (8):49-52. PubMed ID: 3932999
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of x-ray irradiation on the biological properties of Mycobacterium tuberculosis].
    Golyshevskaia VI; Bibergal' EA
    Probl Tuberk; 1985; (8):53-6. PubMed ID: 3933000
    [No Abstract]   [Full Text] [Related]  

  • 10. Filtrable forms of mycobacteria tuberculosis.
    Khomenko AG; Golyshevskaya VI
    Z Erkr Atmungsorgane; 1984; 162(2):147-54. PubMed ID: 6429959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Isolation and study of the morphological properties and immunogenicity of filterable forms of Mycobacterium tuberculosis].
    Khomenko AG; Golyshevskaia VI; Korolev MB; Litvinov VI; Il'ina IN
    Zh Mikrobiol Epidemiol Immunobiol; 1983 May; (5):32-6. PubMed ID: 6410622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intermittent chemotherapy of patients with fibrous-cavernous pulmonary tuberculosis in a hospital].
    Kovalenko NN; Ginzburg TS; Kunichkina SA
    Probl Tuberk; 1987; (11):35-7. PubMed ID: 3125538
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of 3H-thymidine to study the metabolism of Mycobacterium tuberculosis as changed during chemotherapy].
    Golyshevskaia VI; Bibergal' EA
    Probl Tuberk; 1988; (10):50-3. PubMed ID: 3148133
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evaluation of various schedules of chemotherapy of newly detected cases of infiltrative pulmonary tuberculosis].
    Volosevich GV; Byshnev II
    Probl Tuberk; 1989; (4):70-1. PubMed ID: 2499881
    [No Abstract]   [Full Text] [Related]  

  • 15. [Dynamics of bacterial populations in experimental destructive pulmonary tuberculosis under treatment].
    Golişevskaia V
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1981; 30(2):111-4. PubMed ID: 6264575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Toward a modern treatment of pulmonary tuberculosis. 2. Bacteriologic and pharmacologic bases and short-term treatment].
    Zegaya M
    Tunis Med; 1984 Nov; 62(7):487-94. PubMed ID: 6442475
    [No Abstract]   [Full Text] [Related]  

  • 17. [Efficacy of chemotherapy of pulmonary tuberculosis drug-resistant m.tuberculosis].
    Khomenko AG; Chukanov VI; Korneev AA
    Probl Tuberk; 1996; (6):42-4. PubMed ID: 9019768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical significance of Mycobacterium tuberculosis polydrug resistance in chronic destructive forms of pulmonary tuberculosis].
    Bialik IB; Klimenko MT
    Probl Tuberk; 1980 Oct; (10):68-70. PubMed ID: 6776517
    [No Abstract]   [Full Text] [Related]  

  • 19. [Problems in the treatment of patients with pulmonary tuberculosis].
    Chukanov VI
    Probl Tuberk; 1997; (4):17-9. PubMed ID: 9333807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New cases of pulmonary tuberculosis treatment within DOTS strategy].
    Zhangireev AA; Ismailov ShSh; Berikova EM
    Probl Tuberk; 2000; (3):23-5. PubMed ID: 10900979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.